相似文献
1
Nano-enabled delivery of diverse payloads across complex biological barriers.
J Control Release. 2015 Dec 10;219:548-559. doi: 10.1016/j.jconrel.2015.08.039. Epub 2015 Aug 24.
2
Alteration of tumor microenvironment for improved delivery and intratumor distribution of nanocarriers.
Biol Pharm Bull. 2013;36(5):692-7. doi: 10.1248/bpb.b13-00121.
3
Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer.
Adv Drug Deliv Rev. 2017 Jun 1;115:98-114. doi: 10.1016/j.addr.2017.03.004. Epub 2017 Apr 7.
4
Nanoparticles as a Carrier System for Drug Delivery Across Blood Brain Barrier.
Curr Drug Metab. 2017;18(2):129-137. doi: 10.2174/1389200218666170113125132.
5
Intracellular transport of nanocarriers across the intestinal epithelium.
Drug Discov Today. 2016 May;21(5):856-63. doi: 10.1016/j.drudis.2016.04.007. Epub 2016 Apr 14.
6
Intranasal delivery of nanoparticle encapsulated tarenflurbil: A potential brain targeting strategy for Alzheimer's disease.
Eur J Pharm Sci. 2016 Sep 20;92:224-34. doi: 10.1016/j.ejps.2016.05.012. Epub 2016 May 14.
7
PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
J Control Release. 2015 Aug 10;211:134-43. doi: 10.1016/j.jconrel.2015.06.002. Epub 2015 Jun 6.
8
Linkers: The key elements for the creation of efficient nanotherapeutics.
J Control Release. 2018 Jan 28;270:260-267. doi: 10.1016/j.jconrel.2017.12.007. Epub 2017 Dec 12.
9
Advanced nanocarriers based on heparin and its derivatives for cancer management.
Biomacromolecules. 2015 Feb 9;16(2):423-36. doi: 10.1021/bm501532e. Epub 2015 Jan 5.
10
Nano-enabled delivery systems across the blood-brain barrier.
Arch Pharm Res. 2014 Jan;37(1):24-30. doi: 10.1007/s12272-013-0272-6. Epub 2013 Oct 30.
引用本文的文献
1
Systematic review of extracellular vesicle-derived microRNAs involved in organ fibrosis: implications for arthrofibrosis therapy.
J Transl Med. 2025 Jul 17;23(1):802. doi: 10.1186/s12967-025-06810-x.
2
Engineered hybrid cell membrane nanosystems for treating cardiovascular diseases.
Mater Today Bio. 2025 Jun 17;33:101992. doi: 10.1016/j.mtbio.2025.101992. eCollection 2025 Aug.
3
Biotechnological approaches and therapeutic potential of mitochondria transfer and transplantation.
Nat Commun. 2025 Jul 1;16(1):5709. doi: 10.1038/s41467-025-61239-6.
4
Current and Near-Future Technologies to Quantify Nanoparticle Therapeutic Loading Efficiency and Surface Coating Efficiency with Targeted Moieties.
Bioengineering (Basel). 2025 Mar 31;12(4):362. doi: 10.3390/bioengineering12040362.
5
Neuroprotective effects of L-Dopa-modified zinc oxide nanoparticles on the rat model of 6-OHDA-ınduced Parkinson's disease.
Sci Rep. 2024 Aug 17;14(1):19077. doi: 10.1038/s41598-024-69324-4.
6
Nanoparticle-neutrophils interactions for autoimmune regulation.
Adv Drug Deliv Rev. 2024 Jun;209:115316. doi: 10.1016/j.addr.2024.115316. Epub 2024 Apr 23.
7
Therapeutic synthetic and natural materials for immunoengineering.
Chem Soc Rev. 2024 Feb 19;53(4):1789-1822. doi: 10.1039/d3cs00805c.
8
Aggregation-Inhibiting scFv-Based Therapies Protect Mice against AAV1/2-Induced A53T-α-Synuclein Overexpression.
Biomolecules. 2023 Jul 31;13(8):1203. doi: 10.3390/biom13081203.
9
Perspective insights into hydrogels and nanomaterials for ischemic stroke.
Front Cell Neurosci. 2023 Jan 24;16:1058753. doi: 10.3389/fncel.2022.1058753. eCollection 2022.
10
Noncoding RNA therapeutics for substance use disorder.
Adv Drug Alcohol Res. 2022;2. doi: 10.3389/adar.2022.10807. Epub 2022 Dec 20.
本文引用的文献
1
Cellular Internalization Mechanisms of Polyanhydride Particles: Implications for Rational Design of Drug Delivery Vehicles.
J Biomed Nanotechnol. 2016 Jul;12(7):1544-52. doi: 10.1166/jbn.2016.2259.
2
Polyanhydride Nanoparticle Delivery Platform Dramatically Enhances Killing of Filarial Worms.
PLoS Negl Trop Dis. 2015 Oct 23;9(10):e0004173. doi: 10.1371/journal.pntd.0004173. eCollection 2015.
3
Biodegradable Particulate Carrier Formulation and Tuning for Targeted Drug Delivery.
J Biomed Nanotechnol. 2015 Apr;11(4):555-77. doi: 10.1166/jbn.2015.2017.
4
Positron Emission Tomography Based Elucidation of the Enhanced Permeability and Retention Effect in Dogs with Cancer Using Copper-64 Liposomes.
ACS Nano. 2015 Jul 28;9(7):6985-95. doi: 10.1021/acsnano.5b01324. Epub 2015 Jun 12.
5
Biodistribution and trafficking of hydrogel nanoparticles in adult mosquitoes.
PLoS Negl Trop Dis. 2015 May 21;9(5):e0003745. doi: 10.1371/journal.pntd.0003745. eCollection 2015 May.
6
Biodistribution and Toxicity Studies of PRINT Hydrogel Nanoparticles in Mosquito Larvae and Cells.
PLoS Negl Trop Dis. 2015 May 21;9(5):e0003735. doi: 10.1371/journal.pntd.0003735. eCollection 2015 May.
7
The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells.
Pestic Biochem Physiol. 2015 May;120:5-13. doi: 10.1016/j.pestbp.2014.12.021. Epub 2014 Dec 23.
8
Development of a liposome formulation for improved biodistribution and tumor accumulation of pentamidine for oncology applications.
Int J Pharm. 2015 Jul 5;488(1-2):154-64. doi: 10.1016/j.ijpharm.2015.04.060. Epub 2015 Apr 21.
9
Exosomes as drug delivery vehicles for Parkinson's disease therapy.
J Control Release. 2015 Jun 10;207:18-30. doi: 10.1016/j.jconrel.2015.03.033. Epub 2015 Mar 31.
10
Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats.
ACS Nano. 2015 May 26;9(5):4850-71. doi: 10.1021/nn506408v. Epub 2015 Apr 22.
Zotero 插件